Physician profile
Randall Ryan
NPI 1255489209
$703.13
in general payments reported to CMS, 2019-2025
12 companies · $354 in 2025
The $354 reported for 2025 was more than what 75% of Neuromusculoskeletal Medicine & Omm providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.55 · 2020: $15.82 · 2021: $101 · 2023: $164 · 2024: $42.75 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $171.94 | 2025 | |
| Endo USA, INC. | $123.04 | 2025 | Xiaflex |
| Zimmer Biomet Holdings, INC. | $122.77 | 2021-2023 | Echo |
| Davol INC. | $89.58 | 2023 | Arista Ah Flexitip |
| Stryker Corporation | $47.15 | 2023-2025 | Gamma, Variax |
| Smith+Nephew, INC. | $27.68 | 2024 | Real Intelligence |
| Djo, LLC | $27.46 | 2021-2024 | Procare |
| Medtronic USA, INC. | $25.55 | 2019 | |
| Dynasplint Systems INC. | $19.20 | 2023 | Dynasplint |
| Ethicon US, LLC | $18.14 | 2025 | Stratafix |
| Kci USA, INC. | $15.82 | 2020 | |
| Heron Therapeutics, INC. | $14.80 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.